retatrutide approval Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Trial of next-gen weight-loss drug

Store the product under recommended laboratory conditions while protecting it from excessive heat, moisture, direct sunlight, and repeated temperature fluctuations

[email protected] These authors have contributed equally to this work This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

As scientists continue to search for therapies that reverse or halt neurological deterioration, one compound is showing exceptional promise Dihexa

Most GLP-1 prescriptions are written by primary care physicians, endocrinologists, and telehealth providers who may have limited training in eating disorder identification

It is prohibited at all times under the 2026 Prohibited List